New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 28, 2014
10:03 EDTMBIIMarrone Bio, Plant & Food Research sign agreement
Marrone Bio Innovations and The New Zealand Institute for Plant & Food Research announced the signing of a collaborative research agreement. The agreement covers a number of novel bio-active organisms and natural products which Plant & Food Research will provide to MBI for the expected development of biopesticides and plant health products. The MBI field of use includes conventional and organic agricultural uses, turf and ornamental, home and garden, and forestry.
News For MBII From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 21, 2015
08:42 EDTMBIIMarrone Bio receives letter of continued noncompliance from Nasdaq
Marrone Bio announced that, as anticipated, it has received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market notifying the company of its continued noncompliance with NASDAQ Listing Rule 5250(c)(1) as a result of the company's failure to timely file its Quarterly Report on Form 10-Q for the three months ended June 30 on August 15. As reported in the company's Notification of Late Filing on Form 12b-25 filed with the SEC on August 17, the Form 10-Q will not be filed with the SEC until after the completion of company management's evaluation of the necessity, nature and scope of any restatements to its previously filed financial statements. The company currently expects that it will be able to file all delinquent reports, including the Form 10-Q, prior the November 9 expiration of the stay on suspension of trading granted by NASDAQ for the company to regain compliance with NASDAQ's filing requirement.
08:40 EDTMBIIMarrone Bio COO James Iademarco to resign
Marrone Bio Innovations announced that James Iademarco, the company's president and COO since January, has elected to resign effective August 31. To assist with the transition of various pending matters, Iademarco has agreed to remain available to advise the company in a consulting capacity for an additional period of up to 90 days.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use